{"id":1275873,"title":"Résumé de recherche du RIEM : Les anticoagulants oraux directs (AOD) dans la maladie thromboembolique veineuse (MTEV) - IRSC","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"fr","captureDate":"2026-03-28","captureTimestamp":"2026-03-28T10:23:16.854000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/f/53236.html?wbdisable=false","snippet":"Résumé de recherche du RIEM Les anticoagulants oraux directs (AOD) dans la maladie thromboembolique veineuse (MTEV) Étude menée par le Réseau canadien pour l’étude observationnelle des médicaments (RCEOM) En comparaison avec la warfarine, le traitement d’une MTEV nouvellement…","rawSnapshotUrl":"/api/snapshots/raw/1275873","browseUrl":"https://replay.healtharchive.ca/job-8/20260328102316/https://cihr-irsc.gc.ca/f/53236.html?wbdisable=false#ha_snapshot=1275873","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}